Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00329628
Status:
COMPLETED
Last Update Posted:
2014-10-28
First Post:
2006-05-24
Brief Title:
Rivaroxaban 10mg Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin
Sponsor:
Bayer
Organization:
Bayer
Organization Data
Organization:
Bayer
Class:
INDUSTRY
Study ID:
11354
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bayer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Therapeutic Area Head
Old Organization:
Bayer HealthCare AG